Clinical Trial Update: Deep Learning-Based OCTA Quantification and Modeling for Predicting Long-Term Anti-VEGF Efficacy in mCNV

View source ↗

Summary

A clinical trial investigating deep learning-based OCTA quantification and modeling to predict long-term anti-VEGF efficacy in myopic choroidal neovascularizati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopic Choroidal Neovascularization

Drugs mentioned

• anti-VEGF therapy

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Myopic Choroidal Neovascularization | Status: NOT_YET_RECRUITING